The technology transfer arm of the UK Medical Research Council has entered into an exclusive licensing agreement with Genentech Inc for access to a series of small molecule drug candidates for neurological disease. Financial terms were not given. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
